Literature DB >> 19940507

Serum transforming growth factor-beta levels depend on allergen exposure in allergic rhinitis.

Giorgio Ciprandi1, Mara De Amici, Mariangela Tosca, Gianluigi Marseglia.   

Abstract

BACKGROUND: Allergic rhinitis (AR) is characterized by inflammation sustained by dysregulated immune response. T-regulatory cells are involved in AR pathogenesis, mainly producing IL-10 and transforming growth factor (TGF)-beta. Indeed, there is a functional and allergen-specific defect of T-regulatory cells in AR. However, there are no data about the influence of allergen exposure on TGF-beta serum levels. Therefore, the aim of this preliminary study was to evaluate TGF-beta serum levels in patients with seasonal AR. Patients were evaluated either outside the pollen season and after 1 preseasonal sublingual immunotherapy (SLIT) course (38 subjects) or during the pollen season (57 subjects).
METHODS: All patients were allergic to Parietaria and/or grasses alone. TGF-beta was measured by a commercially available kit. Symptoms, drug use and eosinophils were evaluated.Serum allergen-specific IgG and IgA levels were also measured by the ELISA method.
RESULTS: TGF-beta serum levels were significantly lower in patients evaluated outside the pollen season in comparison with the other 2 situations. SLIT induced the significantly highest TGF-beta serum levels. There was a significant negative relationship between TGF-beta and eosinophils in patients after SLIT. IgG and IgA levels were higher in SLIT-treated patients.
CONCLUSION: This preliminary study provides evidence that TGF-beta serum levels are significantly dependent on allergen exposure. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19940507     DOI: 10.1159/000260085

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  1 in total

1.  Allergic Rhinitis and Its Relationship with IL-10, IL-17, TGF-β, IFN-γ, IL 22, and IL-35.

Authors:  P Bayrak Degirmenci; S Aksun; Z Altin; F Bilgir; I B Arslan; H Colak; B Ural; D Solakoglu Kahraman; G Diniz; B Ozdemir; C Kırmaz
Journal:  Dis Markers       Date:  2018-03-06       Impact factor: 3.434

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.